We derived and validated a prognostic score that predicted relapse in uveal melanoma based on the weighted expression of only two genes (PTP4A3 and JPH1) and applied it to the prediction of liver relapse in other malignancies. The gene discussed is JPH1; the disease is uveal melanoma.